Qinghai Spring Medicinal Resources Technology Co., Ltd is currently in a long term uptrend where the price is trading 39.7% above its 200 day moving average.

From a valuation standpoint, the stock is 1053.2% more expensive than other stocks from the Energy sector with a price to sales ratio of 28.2.

Qinghai Spring Medicinal Resources Technology Co., Ltd's total revenue sank by 20.1% to $29M since the same quarter in the previous year.

Its net income has dropped by 24.5% to $-39M since the same quarter in the previous year.

Finally, its free cash flow grew by 48.6% to $-27M since the same quarter in the previous year.

Based on the above factors, Qinghai Spring Medicinal Resources Technology Co., Ltd gets an overall score of 2/5.